Vycor Medical, Inc. (VYCO)
0.0672
0.00 (0.00%)
USD |
OTCM |
Sep 10, 16:00
Vycor Medical Gross Profit Margin (Quarterly) : 78.80% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 78.80% |
| March 31, 2026 | 78.78% |
| December 31, 2025 | 76.88% |
| September 30, 2025 | 85.07% |
| June 30, 2025 | 80.66% |
| March 31, 2025 | 78.76% |
| December 31, 2024 | 84.03% |
| September 30, 2024 | 86.77% |
| June 30, 2024 | 87.67% |
| March 31, 2024 | 84.60% |
| December 31, 2023 | 81.73% |
| September 30, 2023 | 84.87% |
| June 30, 2023 | 88.77% |
| March 31, 2023 | 87.48% |
| December 31, 2022 | 80.98% |
| September 30, 2022 | 81.68% |
| June 30, 2022 | 87.04% |
| March 31, 2022 | 84.70% |
| December 31, 2021 | 82.28% |
| September 30, 2021 | 84.07% |
| June 30, 2021 | 88.42% |
| March 31, 2021 | 85.66% |
| December 31, 2020 | 83.92% |
| September 30, 2020 | 80.07% |
| June 30, 2020 | 85.59% |
| Date | Value |
|---|---|
| March 31, 2020 | 84.28% |
| December 31, 2019 | 84.22% |
| September 30, 2019 | 86.31% |
| June 30, 2019 | 87.64% |
| March 31, 2019 | 85.37% |
| December 31, 2018 | 80.16% |
| September 30, 2018 | 80.32% |
| June 30, 2018 | 70.04% |
| March 31, 2018 | 78.07% |
| December 31, 2017 | 45.00% |
| September 30, 2017 | 66.21% |
| June 30, 2017 | 64.67% |
| March 31, 2017 | 72.62% |
| December 31, 2016 | 72.37% |
| September 30, 2016 | 68.91% |
| June 30, 2016 | 69.85% |
| March 31, 2016 | 67.38% |
| December 31, 2015 | 46.16% |
| September 30, 2015 | 51.38% |
| June 30, 2015 | 57.80% |
| March 31, 2015 | 59.10% |
| December 31, 2014 | 56.81% |
| September 30, 2014 | 57.76% |
| June 30, 2014 | 54.87% |
| March 31, 2014 | 61.74% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 52.64% |
| AngioDynamics, Inc. | 50.87% |
| Alphatec Holdings, Inc. | 62.90% |
| AtriCure, Inc. | 76.75% |
| Baxter International, Inc. | 33.55% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -6.53% |
| Profit Margin (Quarterly) | -4.57% |
| Operating Margin (Quarterly) | 1.65% |
| Return on Net Operating Assets | -9.58% |